Amazing, recent progress in prostate cancer research has encouraged many experts (including this writer) to expect that this type of cancer will be cured -- or at least adequately controlled -- within their lifetimes. "I’m glad I had this cancer," states Dr. Paul Lange, "for it made me a more empathetic physician."
The U.S. Prevention Services Task Force released its 2017 draft recommendations for prostate cancer screening. Here we extensively address the new guidelines, clarify the role of the PSA test, and delve deeper into the topic with Dr. David Samadi, Chairman of Urology and Chief of Robotic Surgery at New York's Lenox Hill Hospital.
A study published in this month s Journal of Urology outlines a better than 90% effectiveness of dogs at detecting prostate cancer by sniffing a patient s urine. The researchers, based in Italy, trained two 3-year-old female German Shepherds for 5 months using operant
In an opinion piece published in today s New York Times, Dr. Richard J. Ablin addresses the serious problems with prostate cancer screening. Dr. Ablin discovered the prostate-specific antigen, or PSA, in 1970 (although widespread PSA screening didn t become routine until the 1990s) and it
Prostate-specific antigen (PSA) screening is a commonly ordered test, despite it s being a highly debated public health practice, and despite recent recommendations which continue to condemn the screening strategy. However, despite the US Preventive Services Task Force s (USPSTF) and other experts recommendations against routine
No medical organization recommends the prostate-specific antigen test for older men, and yet many primary care doctors continue to administer it even to those over age 75. Why?